662 related articles for article (PubMed ID: 22339650)
21. A simple work flow for biologically inspired model reduction--application to early JAK-STAT signaling.
Quaiser T; Dittrich A; Schaper F; Mönnigmann M
BMC Syst Biol; 2011 Feb; 5():30. PubMed ID: 21338487
[TBL] [Abstract][Full Text] [Related]
22. Unraveling the Immunogenetics of STAT Proteins: Clinical Perspectives on Gain-of-Function and Loss-of-Function Variants.
Meesilpavikkai K; Hirankarn N; Dalm VASH; Hagen PMV; Dik WA; IJspeert H
Asian Pac J Allergy Immunol; 2024 Jun; 42(2):105-122. PubMed ID: 38710647
[TBL] [Abstract][Full Text] [Related]
23. The Jak/STAT pathway.
Harrison DA
Cold Spring Harb Perspect Biol; 2012 Mar; 4(3):. PubMed ID: 22383755
[TBL] [Abstract][Full Text] [Related]
24. The JAK-STAT pathway: impact on human disease and therapeutic intervention.
O'Shea JJ; Schwartz DM; Villarino AV; Gadina M; McInnes IB; Laurence A
Annu Rev Med; 2015; 66():311-28. PubMed ID: 25587654
[TBL] [Abstract][Full Text] [Related]
25. Molecular pathways: Jak/STAT pathway: mutations, inhibitors, and resistance.
Quintás-Cardama A; Verstovsek S
Clin Cancer Res; 2013 Apr; 19(8):1933-40. PubMed ID: 23406773
[TBL] [Abstract][Full Text] [Related]
26. The JAK-STAT pathway at twenty.
Stark GR; Darnell JE
Immunity; 2012 Apr; 36(4):503-14. PubMed ID: 22520844
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms of Jak/STAT signaling in immunity and disease.
Villarino AV; Kanno Y; Ferdinand JR; O'Shea JJ
J Immunol; 2015 Jan; 194(1):21-7. PubMed ID: 25527793
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic targeting of the Jak/STAT pathway.
Aittomäki S; Pesu M
Basic Clin Pharmacol Toxicol; 2014 Jan; 114(1):18-23. PubMed ID: 24164900
[TBL] [Abstract][Full Text] [Related]
29. Evolution of the JAK-STAT pathway.
Liongue C; Ward AC
JAKSTAT; 2013 Jan; 2(1):e22756. PubMed ID: 24058787
[TBL] [Abstract][Full Text] [Related]
30. Adult haemophagocytic syndrome.
Ramos-Casals M; Brito-Zerón P; López-Guillermo A; Khamashta MA; Bosch X
Lancet; 2014 Apr; 383(9927):1503-1516. PubMed ID: 24290661
[TBL] [Abstract][Full Text] [Related]
31. JAK/STAT signaling in hematological malignancies.
Vainchenker W; Constantinescu SN
Oncogene; 2013 May; 32(21):2601-13. PubMed ID: 22869151
[TBL] [Abstract][Full Text] [Related]
32. Targeting the interleukin-6/Jak/stat pathway in human malignancies.
Sansone P; Bromberg J
J Clin Oncol; 2012 Mar; 30(9):1005-14. PubMed ID: 22355058
[TBL] [Abstract][Full Text] [Related]
33. JAK and STAT signaling molecules in immunoregulation and immune-mediated disease.
O'Shea JJ; Plenge R
Immunity; 2012 Apr; 36(4):542-50. PubMed ID: 22520847
[TBL] [Abstract][Full Text] [Related]
34. The molecular details of cytokine signaling via the JAK/STAT pathway.
Morris R; Kershaw NJ; Babon JJ
Protein Sci; 2018 Dec; 27(12):1984-2009. PubMed ID: 30267440
[TBL] [Abstract][Full Text] [Related]
35. Discovery and development of Janus kinase (JAK) inhibitors for inflammatory diseases.
Clark JD; Flanagan ME; Telliez JB
J Med Chem; 2014 Jun; 57(12):5023-38. PubMed ID: 24417533
[TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo characterization of the JAK1 selectivity of upadacitinib (ABT-494).
Parmentier JM; Voss J; Graff C; Schwartz A; Argiriadi M; Friedman M; Camp HS; Padley RJ; George JS; Hyland D; Rosebraugh M; Wishart N; Olson L; Long AJ
BMC Rheumatol; 2018; 2():23. PubMed ID: 30886973
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms and consequences of Jak-STAT signaling in the immune system.
Villarino AV; Kanno Y; O'Shea JJ
Nat Immunol; 2017 Mar; 18(4):374-384. PubMed ID: 28323260
[TBL] [Abstract][Full Text] [Related]
38. Janus kinase inhibition lessens inflammation and ameliorates disease in murine models of hemophagocytic lymphohistiocytosis.
Das R; Guan P; Sprague L; Verbist K; Tedrick P; An QA; Cheng C; Kurachi M; Levine R; Wherry EJ; Canna SW; Behrens EM; Nichols KE
Blood; 2016 Mar; 127(13):1666-75. PubMed ID: 26825707
[TBL] [Abstract][Full Text] [Related]
39. JAK-STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects.
Banerjee S; Biehl A; Gadina M; Hasni S; Schwartz DM
Drugs; 2017 Apr; 77(5):521-546. PubMed ID: 28255960
[TBL] [Abstract][Full Text] [Related]
40. The role of JAK/STAT signaling pathway and its inhibitors in diseases.
Xin P; Xu X; Deng C; Liu S; Wang Y; Zhou X; Ma H; Wei D; Sun S
Int Immunopharmacol; 2020 Mar; 80():106210. PubMed ID: 31972425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
